Voyager Therapeutics, a clinical-stage biotechnology company, is making remarkable strides in the field of neurogenetic medicine. Specializing in gene therapy to address neurological diseases, Voyager is on a mission to leverage human genetics to modify the course of these debilitating conditions and ultimately provide cures. The company’s innovative approaches